^
    The Agilent SureSelect Cancer CGP Assay is a next-generation sequencing panel designed for somatic variant profiling across a broad range of solid tumor types. The pan-cancer assay comprises 679 genes globally curated from leading cancer databases in partnership with clinical cancer researchers. It detects key classes of somatic variants (SNVs, CNVs, indels, translocations, de novo gene fusions), along with immuno-oncology biomarkers TMB and MSI.
    Cancer:
    Solid Tumor
    Method:
    Next-Generation Sequencing